Terms: = Brain cancer AND PAX5, Q02548, 5079, ENSG00000196092, BSAP AND Prognosis
5 results:
1. Lymphomas of Central Nervous System.
Yokogami K; Azuma M; Takeshima H; Hirai T
Adv Exp Med Biol; 2023; 1405():527-543. PubMed ID: 37452952
[TBL] [Abstract] [Full Text] [Related]
2. Primary central nervous system CD20-negative diffuse large B-cell lymphoma: a case report.
Luo S; Huang X; Li Y; Wang J
BMC Neurol; 2022 Dec; 22(1):504. PubMed ID: 36581860
[TBL] [Abstract] [Full Text] [Related]
3. Primary Intra-Axial Diffuse Large B-Cell Lymphoma in Immunocompetent Patients: Clinical Impact of Molecular Analysis and Histogenetic Evaluation.
Cambruzzi E
World Neurosurg; 2020 Feb; 134():215-220. PubMed ID: 31605845
[TBL] [Abstract] [Full Text] [Related]
4. Long-Term Survival of Primary Intracranial Plasmablastic Lymphoma: Case Report and Review of the Literature.
Ma H; Wei MH; Qin HM; Wang GY; Hu ZC
World Neurosurg; 2017 Jan; 97():750.e5-750.e10. PubMed ID: 27794513
[TBL] [Abstract] [Full Text] [Related]
5. Primary central nervous system histiocytic sarcoma with relapse to mediastinum: a case report and review of the literature.
Cao M; Eshoa C; Schultz C; Black J; Zu Y; Chang CC
Arch Pathol Lab Med; 2007 Feb; 131(2):301-5. PubMed ID: 17284118
[TBL] [Abstract] [Full Text] [Related]
